Boyle James T. Jr.

EVP,CEO of LabCorp Diagnostics at LH

Sold, on record
$24.2M
Dollars the filings state
Form 4 sales
15
Latest Mar 31, 2016
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • LHLABCORP HOLDINGS INC.EVP,CEO of LabCorp Diagnostics

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale LHUnusual
    Jun 9 2014

    Sold 38,600 shares at $103.00 ($4M)

    Boyle James T. Jr., EVP, Chief Operating Officer

    Sold 59.9% of holdings ($6.6M position)25,821 shares left9.4x usual sizeFiling

  2. 2 Form 4 sale LHPlan not stated
    Feb 13 +249 days

    Sold 6,597 shares at $116.68 ($770k)

    Boyle James T. Jr., EVP, Chief Operating Officer

    Sold 20.3% of holdings ($3.8M position)25,821 shares left0.5x usual sizeFiling

  3. 3 Form 4 sale LHPlan not stated
    Mar 3 +18 days

    Sold 1,237 shares at $123.70 ($153k)

    Boyle James T. Jr., EVP, Chief Operating Officer

    Sold 5% of holdings ($3.1M position)23,454 shares left0.2x usual sizeFiling

  4. 4 Form 4 sale LHPlan not stated
    Apr 23 +51 days

    Sold 1,394 shares at $126.56 ($176k)

    Boyle James T. Jr., EVP,CEO of LabCorp Diagnostics

    Sold 5.6% of holdings ($3.1M position)23,454 shares left0.3x usual sizeFiling

  5. 5 Form 4 sale LHPlan not stated
    Feb 12 +295 days

    Sold 2,712 shares at $101.67 ($276k)

    Boyle James T. Jr., EVP,CEO of LabCorp Diagnostics

    Sold 10.4% of holdings ($2.7M position)23,454 shares left1.1x usual sizeFiling

  6. 6 Form 4 sale LHPlan not stated
    Feb 16 +4 days

    Sold 4,055 shares at $103.02 ($418k)

    Boyle James T. Jr., EVP,CEO of LabCorp Diagnostics

    Sold 14.7% of holdings ($2.8M position)23,454 shares left1.6x usual sizeFiling

  7. 7 Form 4 sale LHPlan not stated
    Mar 14 +27 days

    Sold 1,543 shares at $115.32 ($178k)

    Boyle James T. Jr., EVP,CEO of LabCorp Diagnostics

    Sold 6.2% of holdings ($2.9M position)23,454 shares left0.6x usual sizeFiling

  8. 8 Form 4 sale LHUnusual
    Mar 31 +17 days

    Sold 18,132 shares at $116.81 ($2.1M)

    Boyle James T. Jr., EVP,CEO of LabCorp Diagnostics

    Sold 43.6% of holdings ($4.9M position)23,454 shares left6.7x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (15)

Form 144 notices and Form 4 sales by Boyle James T. Jr.
Source
Mar 31, 2016LHEVP,CEO of LabCorp DiagnosticsForm 4 sale18,132$2.1M43.6%UnusualSEC
Mar 14, 2016LHEVP,CEO of LabCorp DiagnosticsForm 4 sale1,543$178k6.2%Plan not statedSEC
Feb 16, 2016LHEVP,CEO of LabCorp DiagnosticsForm 4 sale4,055$418k14.7%Plan not statedSEC
Feb 12, 2016LHEVP,CEO of LabCorp DiagnosticsForm 4 sale2,712$276k10.4%Plan not statedSEC
Apr 23, 2015LHEVP,CEO of LabCorp DiagnosticsForm 4 sale1,394$176k5.6%Plan not statedSEC
Mar 3, 2015LHEVP, Chief Operating OfficerForm 4 sale1,237$153k5.0%Plan not statedSEC
Feb 13, 2015LHEVP, Chief Operating OfficerForm 4 sale6,597$770k20.3%Plan not statedSEC
Jun 9, 2014LHEVP, Chief Operating OfficerForm 4 sale38,600$4M59.9%UnusualSEC
Mar 28, 2014LHEVP, Chief Operating OfficerForm 4 sale2,521$248k8.9%Plan not statedSEC
Mar 3, 2014LHEVP, Chief Operating OfficerForm 4 sale1,582$147k5.8%Plan not statedSEC
Feb 13, 2014LHEVP, Chief Operating OfficerForm 4 sale4,123$372k12.8%Plan not statedSEC
Feb 11, 2014LHEVP, Chief Operating OfficerForm 4 sale1,204$110k4.1%Plan not statedSEC
Oct 17, 2013LHEVP, Chief Operating OfficerForm 4 sale24,400$2.5M44.9%UnusualSEC
Jun 7, 2013LHEVP, Chief Operating OfficerForm 4 sale63,100$6.3M67.8%UnusualSEC
May 10, 2013LHEVP, Chief Operating OfficerForm 4 sale68,908$6.5M69.7%UnusualSEC